Prentiss Smith & Co’s Labcorp LH Stock Holding History

Prentiss Smith & Co’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-233	Closed	-$35K	–	150
2018 Q3	$35K	Buy	+233	New	+$35.4K	0.02%	132
2018 Q2	–	Sell	-233	Closed	-$32K	–	273
2018 Q1	$32K	Hold	233	–	–	0.02%	154
2017 Q4	$32K	Hold	233	–	–	0.02%	157
2017 Q3	$30K	Hold	233	–	–	0.02%	140
2017 Q2	$31K	Buy	+233	New	+$28.5K	0.02%	140
2017 Q1	–	Sell	-233	Closed	-$26K	–	257
2016 Q4	$26K	Hold	233	–	–	0.02%	151
2016 Q3	$27K	Hold	233	–	–	0.02%	154
2016 Q2	$26K	Hold	233	–	–	0.01%	151
2016 Q1	$23K	Hold	233	–	–	0.01%	175
2015 Q4	$25K	Buy	+233	New	+$24K	0.01%	176
2015 Q3	–	Sell	-233	Closed	-$24K	–	348
2015 Q2	$24K	Hold	233	–	–	0.01%	167
2015 Q1	$25K	Buy	+233	New	+$24K	0.01%	186

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Prentiss Smith & Co's LH Position: Q4 2018 in Review

Prentiss Smith & Co sold out of Labcorp (LH) in Q4 2018, closing a stake of 233 shares — an estimated $35K sold.

Prentiss Smith & Co first reported a position in LH in Q1 2015 and held it in 12 quarters. The position peaked at $35K in Q3 2018. 743 funds tracked by Wall St. Rank hold LH as of Q4 2018.

Prentiss Smith & Co reported no remaining Labcorp position as of Q4 2018 after selling out during the quarter.
Prentiss Smith & Co sold 233 Labcorp shares in Q4 2018, an estimated $35K.
Prentiss Smith & Co first reported a position in Labcorp in Q1 2015 and held it in 12 quarters.
Prentiss Smith & Co's Labcorp position peaked at $35K in Q3 2018.
743 funds tracked by Wall St. Rank held Labcorp as of Q4 2018.

Based on Prentiss Smith & Co's 13F filing for Q4 2018, filed 15 Jan 2019.